Hicks, J. K., Quilitz, R. E., Komrokji, R. S., Kubal, T. E., Lancet, J. E., Pasikhova, Y., . . . Greene, J. N. (2019). Prospective CYP2C19-Guided Voriconazole Prophylaxis in Neutropenic AML Patients Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations. Clin Pharmacol Ther.
Chicago Style aipamenaHicks, J. Kevin, et al. "Prospective CYP2C19-Guided Voriconazole Prophylaxis in Neutropenic AML Patients Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations." Clin Pharmacol Ther 2019.
MLA aipamenaHicks, J. Kevin, et al. "Prospective CYP2C19-Guided Voriconazole Prophylaxis in Neutropenic AML Patients Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations." Clin Pharmacol Ther 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.